• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Director Schapiro Richard M sold $214,414 worth of shares (669 units at $320.50), decreasing direct ownership by 6% to 11,244 units (SEC Form 4)

    5/1/25 4:41:05 PM ET
    $MOH
    Medical Specialities
    Health Care
    Get the next $MOH alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Schapiro Richard M

    (Last) (First) (Middle)
    2180 HARVARD STREET
    SUITE 400

    (Street)
    SACRAMENTO CA 95815

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    MOLINA HEALTHCARE, INC. [ MOH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/29/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/29/2025 S 669 D $320.5(1) 11,244 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $320.46 to $320.50. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
    Remarks:
    Jeff D. Barlow, by power of attorney for Richard M. Schapiro. 05/01/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MOH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MOH

    DatePrice TargetRatingAnalyst
    4/22/2025$414.00Outperform
    Bernstein
    4/15/2025$375.00Outperform → Neutral
    Robert W. Baird
    3/5/2025$295.00 → $372.00Equal Weight → Overweight
    Wells Fargo
    12/17/2024$378.00 → $350.00Neutral
    Analyst
    5/30/2024$405.00Outperform
    Robert W. Baird
    3/28/2024$439.00Neutral → Underperform
    BofA Securities
    3/6/2024$437.00Equal Weight
    Barclays
    2/15/2024$367.00 → $420.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $MOH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Molina Healthcare Reports First Quarter 2025 Financial Results

      Reaffirms Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below:   Three months ended   March 31,   2025   2024         (In millions, except per-share results) Premium Revenue $10,628   $9,504 Total Revenue $11,147   $9,931         GAAP:       Net Income $298   $301 EPS – Diluted $5.45   $5.17 Medical Care Ratio (MCR) 89.2%   88.5% G&A Ratio 6.9%   7.2

      4/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Wins Illinois Contract to Provide a Dual Eligible Special Needs Plan

      Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that the Company's subsidiary, Molina Healthcare of Illinois, Inc., was one of four managed care organizations awarded a contract by the Illinois Department of Healthcare and Family Services to provide a Fully Integrated Dual Eligible Special Needs Plan (D-SNP). This contract will replace the State's Medicare-Medicaid Alignment Initiative (MMAI) demonstration program, which currently serves approximately 73,000 beneficiaries. The go-live date for the new contract is expected to be January 1, 2026. The contract is expected to have an initial term of four years, with the option to extend the contract from the init

      3/18/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces First Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the first quarter ending March 31, 2025, after the market closes on Wednesday, April 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, April 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 3317326. A telephonic replay of the conference call will be available through Thursday, May 1, 2025, by dialing (877) 344-7529 and entering the confirmation number, 6106565. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relations

      3/5/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Orlando Steven J sold $318,580 worth of shares (1,000 units at $318.58) (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      5/5/25 4:36:49 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Director Grohowski Leo P was granted 118 shares (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      5/2/25 4:43:52 PM ET
      $MOH
      Medical Specialities
      Health Care
    • New insider Grohowski Leo P claimed no ownership of stock in the company (SEC Form 3)

      3 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      5/2/25 4:40:53 PM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/14/24 1:22:34 PM ET
      $MOH
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Molina Healthcare Inc

      SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/12/24 12:53:29 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/8/24 10:34:33 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Financials

    Live finance-specific insights

    See more
    • Molina Healthcare Reports First Quarter 2025 Financial Results

      Reaffirms Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below:   Three months ended   March 31,   2025   2024         (In millions, except per-share results) Premium Revenue $10,628   $9,504 Total Revenue $11,147   $9,931         GAAP:       Net Income $298   $301 EPS – Diluted $5.45   $5.17 Medical Care Ratio (MCR) 89.2%   88.5% G&A Ratio 6.9%   7.2

      4/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces First Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the first quarter ending March 31, 2025, after the market closes on Wednesday, April 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, April 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 3317326. A telephonic replay of the conference call will be available through Thursday, May 1, 2025, by dialing (877) 344-7529 and entering the confirmation number, 6106565. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relations

      3/5/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Reports Fourth Quarter and Year-End 2024 Financial Results

      Introduces Full Year 2025 Revenue and Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported fourth quarter 2024 GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted share of $5.05. The Company also reported full year 2024 GAAP earnings per diluted share of $20.42 and adjusted earnings per diluted share of $22.65. Financial results are summarized below:   Three months ended   Year ended   December 31,   December 31,   2024   2023   2024   2023                 (In millions, except per-s

      2/5/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bernstein initiated coverage on Molina Healthcare with a new price target

      Bernstein initiated coverage of Molina Healthcare with a rating of Outperform and set a new price target of $414.00

      4/22/25 7:34:03 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded Molina Healthcare from Outperform to Neutral and set a new price target of $375.00

      4/15/25 9:27:54 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Molina Healthcare from Equal Weight to Overweight and set a new price target of $372.00 from $295.00 previously

      3/5/25 7:37:05 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Molina Healthcare Inc

      SCHEDULE 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      5/14/25 10:45:26 AM ET
      $MOH
      Medical Specialities
      Health Care
    • SEC Form S-8 filed by Molina Healthcare Inc

      S-8 - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      5/1/25 4:26:20 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Inc filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      5/1/25 4:17:16 PM ET
      $MOH
      Medical Specialities
      Health Care